This was echoed in other general population [ 42 ] and CJS papers [ 15 , 16 ], and is highly significant in the prison setting given the compounded stigma often experienced by this population [ 43 ].
← all excerpts
Long-Acting Injectable Buprenorphine in Prison: Insights From a Short-Answer Survey of People in the Criminal Justice System Commencing Long-Acting Injectable Buprenorphine During a Non-Randomised Clinical Trial.
1
—
—